Status:
TERMINATED
COVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of Denmark
Lead Sponsor:
Anders Fink-Jensen, MD, DMSci
Conditions:
Covid19
Severe Mental Disorder
Eligibility:
All Genders
18+ years
Brief Summary
The pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has lately caused worldwide health problems. Patients suffering from a se...
Detailed Description
Patients suffering from severe mental illness could be in increased risk for a severe outcome if infected with COVID-19. Also, there are reports on fewer treatment activities among psychiatric patient...
Eligibility Criteria
Inclusion
- Informed oral and written consent
- Age ≥ 18 years
- Patients with a diagnosis of schizophrenia, schizoaffective disorder or a bipolar affective disorder, according to the criteria of ICD10 (International Classification of Diseases, World Health Organization (WHO))
- Receiving psychiatric treatment from a hospital in- or outpatient-clinic in the catchment area of the Capital Region of Denmark
Exclusion
- 1\. Patient with signs of infection should initially be transferred to the national test centres antigen-PCR testing. These patients will be offered to participate in next blood sampling interval.
Key Trial Info
Start Date :
January 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
1355 Patients enrolled
Trial Details
Trial ID
NCT04775407
Start Date
January 18 2021
End Date
June 1 2021
Last Update
September 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatric Centre Copenhagen
Copenhagen, Denmark, 2100